Nature Communications (May 2019)

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy

  • Carlota Dobaño,
  • Hèctor Sanz,
  • Hermann Sorgho,
  • David Dosoo,
  • Maximilian Mpina,
  • Itziar Ubillos,
  • Ruth Aguilar,
  • Tom Ford,
  • Núria Díez-Padrisa,
  • Nana Aba Williams,
  • Aintzane Ayestaran,
  • Ousmane Traore,
  • Augusto J. Nhabomba,
  • Chenjerai Jairoce,
  • John Waitumbi,
  • Selidji Todagbe Agnandji,
  • Simon Kariuki,
  • Salim Abdulla,
  • John J. Aponte,
  • Benjamin Mordmüller,
  • Kwaku Poku Asante,
  • Seth Owusu-Agyei,
  • Halidou Tinto,
  • Joseph J. Campo,
  • Gemma Moncunill,
  • Ben Gyan,
  • Clarissa Valim,
  • Claudia Daubenberger

DOI
https://doi.org/10.1038/s41467-019-10195-z
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 13

Abstract

Read online

RTS,S/AS01E has been tested in a phase 3 malaria vaccine trial and has shown partial efficacy in children and infants. Here, the authors analyze IgG concentration and avidity to CSP in ~1000 participants and show that IgG avidity to the C-terminus of CSP is significantly associated with vaccine-mediated protection.